Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Amgen inc. crawled time : 06:00 save search
Sandoz Marketing Authorization Applications for proposed biosimilar denosumab accepted by EMA
Published: 2023-05-25 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -0.89%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.55%
H: 0.0%
C: -1.2%
biosimilar authorization ema
COINBASE GLOBAL, INC. (NASDAQ: COIN) INVESTIGATION ALERT: Bernstein Liebhard is investigating possible securities claims against Coinbase Global, Inc.
Published: 2023-03-27 (Crawled : 06:00) - prnewswire.com
CSGKF | $0.89 4.69% 51K
|
Finance
|
| O: -0.98%
H: 0.0%
C: -1.9%
COIN S | $224.345 -5.11% -5.39% 6.7M
|
|
| O: -0.93%
H: 0.6%
C: -6.93%
CS | $0.8858 1.49% 64M
|
Finance
|
| O: 3.75%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.66%
H: 0.14%
C: -1.19%
Sandoz announces further progress on its biosimilar pipeline, with release of positive results for denosumab integrated Phase I/III clinical trial
Published: 2022-09-19 (Crawled : 06:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.52%
H: 0.69%
C: 0.62%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.22%
H: 0.1%
C: 0.05%
biosimilar trial positive
MOLN DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Molecular Partners AG Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - MOLN
Published: 2022-09-07 (Crawled : 06:00) - prnewswire.com
MOLN | $3.88 -3.54% 200
|
Professional, Scientific, and T...
|
| O: 1.61%
H: 2.81%
C: 0.18%
TWTR | $53.7 0.3%
|
Technology Services
|
| O: 1.73%
H: 4.96%
C: 4.83%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.24%
H: 1.04%
C: 0.82%
molecular deadline
Generic Drugs Market to record USD 138.9 Bn growth -- Technavio identifies North America as a key growth region
Published: 2022-07-27 (Crawled : 06:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.1%
H: 1.96%
C: 1.41%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.43%
H: 0.51%
C: 0.32%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.79%
H: 1.44%
C: 1.03%
america growth market
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published: 2022-07-25 (Crawled : 06:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 3.12%
H: 0.06%
C: 0.06%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: 0.19%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
ADCT | $4.78 -3.82% 0.0% 280K
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -2.31%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: -7.8%
H: 3.72%
C: 2.37%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.37%
H: 0.9%
C: 0.75%
therapeutics market
Vascular Endothelial Growth Factor (VGEF) Inhibitors Market: 36% Market Growth to Originate from North America | Technavio
Published: 2022-05-17 (Crawled : 06:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 4.22%
H: 0.0%
C: -2.05%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.55%
H: 0.0%
C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.54%
H: 3.32%
C: 2.78%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.63%
H: 0.0%
C: 0.0%
BHC | $8.56 0.35% 0.0% 2M
|
Health Technology
|
| O: 2.79%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.46%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.5%
H: 0.64%
C: 0.19%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
america growth market
EUROPEAN COMMISSION APPROVES LUMYKRAS® (SOTORASIB) FOR PATIENTS WITH KRAS G12C-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER
Published: 2022-01-10 (Crawled : 06:00) - prnewswire.com
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 2.3%
H: 0.0%
C: 0.0%
cancer
USD 138.90 bn growth in Generic Drugs Market from 2021 to 2025|Technavio
Published: 2021-10-08 (Crawled : 06:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
|
| O: 3.76%
H: 0.0%
C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.44%
H: 1.0%
C: -0.44%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.64%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.34%
H: 0.0%
C: 0.0%
drug growth
Press release Biocartis Group NV: BIOCARTIS Q1 2021 BUSINESS UPDATE
Published: 2021-04-22 (Crawled : 06:00) - globenewswire.com
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.48%
H: 0.36%
C: -0.97%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.